Affiliation:
1. University of Colorado, Aurora, USA
Abstract
There are few cases in the literature demonstrating vasculitis induced by tumor necrosis factor–α. There exist even fewer cases of systemic inflammation involving the skin, nerves, and kidneys. Here, we present a novel case of a 27-year-old man with Crohn disease refractory to multiple medications, most recently treated with infliximab. He presented with a 3-week history of non-blanching palpable petechial rash involving his bilateral extremities and right upper extremity as well as lesions with black eschar around his ankles. He was found to have refractory cutaneous small vessel vasculitis, nephrotic range proteinuria, and small fiber neuropathy. This case describes the evaluation and treatment of systemic small vessel vasculitis in the setting of infliximab therapy.
Subject
Safety Research,Safety, Risk, Reliability and Quality,Epidemiology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Renal disease in pediatric rheumatology;Current Opinion in Rheumatology;2024-05-17
2. Dexamethasone/infliximab/prednisone;Reactions Weekly;2023-09-09